Annual ROE
-68.51%
-6.73%-10.89%
March 31, 2024
Summary
- As of February 7, 2025, SNOA annual return on equity is -68.51%, with the most recent change of -6.73% (-10.89%) on March 31, 2024.
- During the last 3 years, SNOA annual ROE has risen by +3.39% (+4.71%).
- SNOA annual ROE is now -216.61% below its all-time high of 58.75%, reached on March 31, 2017.
Performance
SNOA ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-70.27%
-6.35%-9.93%
December 31, 2024
Summary
- As of February 7, 2025, SNOA quarterly return on equity is -70.27%, with the most recent change of -6.35% (-9.93%) on December 31, 2024.
- Over the past year, SNOA quarterly ROE has increased by +6.30% (+8.23%).
- SNOA quarterly ROE is now -101.86% below its all-time high of 3774.75%, reached on June 30, 2012.
Performance
SNOA Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
SNOA ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -10.9% | +8.2% |
| 3 y3 years | +4.7% | -1.5% |
| 5 y5 years | +25.0% | -1.5% |
SNOA ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -10.9% | +5.3% | -26.6% | +23.5% |
| 5 y | 5-year | -66.8% | +25.0% | -261.5% | +23.5% |
| alltime | all time | -216.6% | +96.1% | -101.9% | +97.6% |
Sonoma Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | -70.27%(+9.9%) |
| Sep 2024 | - | -63.92%(-13.9%) |
| Jun 2024 | - | -74.22%(+3.5%) |
| Mar 2024 | -68.51%(+10.9%) | -71.69%(-6.4%) |
| Dec 2023 | - | -76.57%(-16.6%) |
| Sep 2023 | - | -91.85%(+15.6%) |
| Jun 2023 | - | -79.45%(+14.8%) |
| Mar 2023 | -61.78%(-14.6%) | -69.21%(-17.6%) |
| Dec 2022 | - | -83.99%(+34.3%) |
| Sep 2022 | - | -62.54%(+12.6%) |
| Jun 2022 | - | -55.52%(-9.8%) |
| Mar 2022 | -72.35%(+0.6%) | -61.56%(-4.7%) |
| Dec 2021 | - | -64.57%(+6.3%) |
| Sep 2021 | - | -60.77%(+4.1%) |
| Jun 2021 | - | -58.40%(+36.8%) |
| Mar 2021 | -71.90%(+75.1%) | -42.68%(+119.5%) |
| Dec 2020 | - | -19.44%(-20.8%) |
| Sep 2020 | - | -24.56%(-35.1%) |
| Jun 2020 | - | -37.82%(+12.3%) |
| Mar 2020 | -41.06%(-55.1%) | -33.69%(-20.1%) |
| Dec 2019 | - | -42.19%(-20.8%) |
| Sep 2019 | - | -53.27%(-17.9%) |
| Jun 2019 | - | -64.90%(-31.2%) |
| Mar 2019 | -91.40%(+17.2%) | -94.28%(-6.2%) |
| Dec 2018 | - | -100.54%(-2.3%) |
| Sep 2018 | - | -102.87%(+10.9%) |
| Jun 2018 | - | -92.74%(+11.0%) |
| Mar 2018 | -77.96%(-232.7%) | -83.52%(+29.9%) |
| Dec 2017 | - | -64.30%(-247.6%) |
| Sep 2017 | - | 43.56%(-19.8%) |
| Jun 2017 | - | 54.34%(-20.1%) |
| Mar 2017 | 58.75%(-164.2%) | 67.98%(-13.6%) |
| Dec 2016 | - | 78.71%(-165.2%) |
| Sep 2016 | - | -120.74%(+13.6%) |
| Jun 2016 | - | -106.25%(+11.2%) |
| Mar 2016 | -91.57%(+34.6%) | -95.51%(+11.0%) |
| Dec 2015 | - | -86.01%(-17.7%) |
| Sep 2015 | - | -104.45%(+15.3%) |
| Jun 2015 | - | -90.61%(+29.7%) |
| Mar 2015 | -68.03% | -69.85%(-1026.4%) |
| Dec 2014 | - | 7.54%(-89.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2014 | - | 69.18%(-15.0%) |
| Jun 2014 | - | 81.39%(+3.3%) |
| Mar 2014 | 46.27%(-113.7%) | 78.77%(-137.7%) |
| Dec 2013 | - | -208.73%(-39.2%) |
| Sep 2013 | - | -343.36%(-12.5%) |
| Jun 2013 | - | -392.47%(-10.7%) |
| Mar 2013 | -338.06%(-80.8%) | -439.26%(-58.2%) |
| Dec 2012 | - | -1049.91%(-142.1%) |
| Sep 2012 | - | 2494.91%(-33.9%) |
| Jun 2012 | - | 3774.75%(-228.5%) |
| Mar 2012 | -1759.66%(+868.2%) | -2938.65%(+291.6%) |
| Dec 2011 | - | -750.41%(+99.4%) |
| Sep 2011 | - | -376.33%(+44.7%) |
| Jun 2011 | - | -260.02%(+41.0%) |
| Mar 2011 | -181.75%(+2.8%) | -184.35%(+21.6%) |
| Dec 2010 | - | -151.57%(+28.4%) |
| Sep 2010 | - | -118.07%(-15.5%) |
| Jun 2010 | - | -139.73%(-25.3%) |
| Mar 2010 | -176.77%(-11.4%) | -187.02%(-30.2%) |
| Dec 2009 | - | -267.86%(-20.4%) |
| Sep 2009 | - | -336.37%(-12.2%) |
| Jun 2009 | - | -383.28%(+53.5%) |
| Mar 2009 | -199.54%(+48.8%) | -249.68%(+3.8%) |
| Dec 2008 | - | -240.59%(+16.3%) |
| Sep 2008 | - | -206.81%(+15.8%) |
| Jun 2008 | - | -178.61%(+8.2%) |
| Mar 2008 | -134.12%(-24.6%) | -165.07%(-34.2%) |
| Dec 2007 | - | -250.93%(-14.7%) |
| Sep 2007 | - | -294.23%(-11.7%) |
| Jun 2007 | - | -333.11%(-21.4%) |
| Mar 2007 | -177.91%(-63.3%) | -423.83%(-55.5%) |
| Dec 2006 | - | -953.00%(+51.4%) |
| Sep 2006 | - | -629.36%(+104.7%) |
| Jun 2006 | - | -307.44%(-2.3%) |
| Mar 2006 | -484.26%(-68.9%) | -314.79%(-66.3%) |
| Dec 2005 | - | -933.42%(+14.1%) |
| Sep 2005 | - | -817.85%(+4.3%) |
| Jun 2005 | - | -784.29%(+4.5%) |
| Mar 2005 | -1557.23%(+320.3%) | -750.73% |
| Mar 2003 | -370.50%(+1985.0%) | - |
| Mar 2002 | -17.77% | - |
FAQ
- What is Sonoma Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Sonoma Pharmaceuticals?
- What is Sonoma Pharmaceuticals annual ROE year-on-year change?
- What is Sonoma Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Sonoma Pharmaceuticals?
- What is Sonoma Pharmaceuticals quarterly ROE year-on-year change?
What is Sonoma Pharmaceuticals annual return on equity?
The current annual ROE of SNOA is -68.51%
What is the all time high annual ROE for Sonoma Pharmaceuticals?
Sonoma Pharmaceuticals all-time high annual return on equity is 58.75%
What is Sonoma Pharmaceuticals annual ROE year-on-year change?
Over the past year, SNOA annual return on equity has changed by -6.73% (-10.89%)
What is Sonoma Pharmaceuticals quarterly return on equity?
The current quarterly ROE of SNOA is -70.27%
What is the all time high quarterly ROE for Sonoma Pharmaceuticals?
Sonoma Pharmaceuticals all-time high quarterly return on equity is 3774.75%
What is Sonoma Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, SNOA quarterly return on equity has changed by +6.30% (+8.23%)